LOS GATOS, Calif., Oct. 23, 2024 /PRNewswire/ — Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced today the first-in-human trans-septal implantations using the 28 Fr. (French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved…
Tag: Tioga Cardiovascular
TIOGA CARDIOVASCULAR, A SHIFAMED PORTFOLIO COMPANY, CLOSES $30M IN SERIES C FINANCING
Funding to advance product development and initiate clinical experience of company’s next-generation technology for transseptal mitral valve replacement LOS GATOS, Calif., Feb. 9, 2023 /PRNewswire/ — Tioga Cardiovascular, a Shifamed portfolio company that aims to redefine structural heart valve replacement, announced today the first closing of its $30M Series C financing. Led by Cormorant Asset Management, […]



